AZTA vs ELV: fair value comparison
Azenta, Inc. and Elevance Health, Inc. · Updated 2026-08-31
Both currently screen as fairly valued on TickrTrends' Forward Fair Value model. Within Healthcare, ELV currently sits closer to the top of our discount ranking.
| AZTA | ELV | |
|---|---|---|
| Verdict | Fairly valued | Fairly valued |
| Last price | $29.88 | $394.43 |
| 12-month range | $21.18–$37.53 | $294.07–$402.66 |
| Sector rank | #74 of 113 Healthcare | #71 of 113 Healthcare |
| Quality grade | D | D |
| Leverage | Low | Moderate |
| Margin trend | — | Stable |
| Revenue growth | — | Modest |
| RSI zone | Neutral | Neutral |
| 50/200-day trend | Uptrend | — |
| DCF cross-check | — | Undervalued |
| 52-week position | The upper-middle quarter | The top quarter |
Full single-stock breakdowns: AZTA fair value analysis · ELV fair value analysis